Natarajan Sethuraman, President, Research & Develop: Entrada Therapeutics TRDA Sell · Filed 24/12/03

Trade details

Type: Insider sale
Amount: $235,815.45
Shares · price: 11,703 sh · $20.15 a share
Held after: 144,997 sh
Stock: Entrada Therapeutics TRDA
Person: Natarajan SethuramanPresident, Research & Develop
Trade date: 24/12/03
Filed: 24/12/03
Days to filing: 0 days

Sold 7.5% of holdings

Share of holding sold: 7.5%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/03~25/01/02

Natarajan Sethuraman's recent trades

Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$398.7K
25,907 sh
$398.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$375.7K
25,907 sh
$375.7K
Filed 05/04
Traded 05/04
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$82.8K
4,088 sh
$82.8K
Filed 24/12/03
Traded 24/12/02
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$2,000
100 sh
$2,000
Filed 24/12/03
Traded 24/11/29
Natarajan SethuramanPresident, Research & Develop
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$54.1K
2,700 sh
$54.1K
Filed 24/11/13
Traded 24/11/13

Natarajan Sethuraman, President — sold $235.8K of Entrada Therapeutics TRDA · 7.5% of holdings · 10b5-1 plan | Whalegun